Indian Billionaires Bet Big on Head Start in Coronavirus Vaccine Race  The New York TimesView Full Coverage on Google News
The world’s largest vaccine producer, the Serum Institute, announced a plan to make hundreds of millions of doses of an unproven inoculation. It’s a gamble with a huge upside. And huge risks.The world’s largest vaccine producer, the Serum Institute, announced a plan to make hundreds of millions of doses of an unproven inoculation. It’s a gamble with a huge upside. And huge risks.

The DCGI had earlier asked SII to clearly define Phase 2 and Phase 3 of trials and resubmit their application for evaluation. The DCGI had earlier asked SII to clearly define Phase 2 and Phase 3 of trials and resubmit their application for evaluation.

Oxford COVID-19 vaccine: Panel recommends that DCGI grant Serum Institute permission for human trials - India News , Firstpost

SII had submitted a revised proposal on Wednesday after the expert panel had asked it to revise its protocol for the trials besides seeking some additional information

COVID-19 panel recommends DCGI to permit SII to conduct human trials of Oxford vaccine candidate - Express Pharma

The development comes three days after the Subject Expert Committee (SEC) for Covid-related therapies on Tuesday recommended amendments to Serum’s earlier protocol to conduct the trials here.The development comes three days after the Subject Expert Committee (SEC) for Covid-related therapies on Tuesday recommended amendments to Serum’s earlier protocol to conduct the trials here.

Panel recommends nod to Serum for late-stage Oxford vaccine trials | India News,The Indian Express

covid shield covishield serum institute covishield india covishield vaccine news covishield vaccine in india covid shield india covishield oxford covishield oxford vaccine covid vaccine oxford covid vaccine trial covid vaccine italy covid vaccine usa covid vaccine updates covid vaccine price covid vaccine india status covid vaccine aiimsAbout 1,600 people aged above 18 will participate in the trials across 17 selected sites, including AIIMS Delhi, BJ Medical College, Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) Patna etc

COVID-19 Vaccine: Pune Firm Gets Nod For Human Trial of Covishield, 1,600 People to Participate

Central Drugs Standard Control Organisation (CDSCO) has recommended the Drug Controller to grant permission to Serum Institute if India to begin the final phase of human trials for Covid vaccine CovishieldCentral Drugs Standard Control Organisation (CDSCO) has recommended the Drug Controller to grant permission to Serum Institute if India to begin the final phase of human trials for Covid vaccine Covishield

India Inches Closer Towards Oxford Vaccine, Panel Recommends DCGI To Permit SII For Human Trials